Ali Mohamed, Ph.D., is Senior Vice President of CMC at Immatics, where he leads process development, analytical development, and GMP manufacturing for the company’s cell therapy portfolio. Since joining Immatics in 2016, he has played a key role in advancing manufacturing capabilities and supporting the development of innovative adoptive cell therapies.

Dr. Mohamed brings more than 20 years of experience in cell and gene therapy development, manufacturing, and GMP operations, with prior leadership roles at Hitachi PCT, AlloCure, Lonza, and Osiris Therapeutics. He holds a Ph.D. in Biomedical Sciences (Pharmacology) from the University of Toledo and a B.S. in Pharmaceutical Sciences from Cairo University.